You are here: Industry Insights > MES

News List

The Role of Exosomes in Drug Delivery: A Natural Alternative to Synthetic Nanocarriers? Nurah Ekhlaque
April 09, 2025
Explore how exosome-based nanocarriers are shaping precision medicine by supporting targeted drug delivery in cancer and neurodegenerative diseases, with potential for reduced side effects.
Advances in the Research and Application of Exosomes in Disease Detection and Diagnosis Xiaonisha
September 03, 2025
Exosomes are vesicles secreted by cells that are widely present in various bodily fluids such as blood, urine, saliva, milk, and have a particle size ranging from 30 to 150 nanometers.
Golden Pen Award | Research Progress on the Application of Exosomes in Drug Delivery Xiaonisha
September 02, 2025
Exosomes are specific membrane vesicles secreted by various types of cells under normal or pathological conditions, playing a vital role in intercellular communication and exchange of information.
Golden Pen Award | Functional Characteristics and Therapeutic Applications of Human Umbilical Cord Mesenchymal Stem Cells in Disease Treatment Xiaonisha
August 27, 2025
Mesenchymal stem cells (MSCs) are a type of adult stem cells derived from the mesoderm that possess self-renewal and multi-directional differentiation potential.
Mechanisms of Mesenchymal Stem Cells in Inhibiting Scar Formation and Methods to Enhance Skin Repair Efficiency Xiaonisha
August 22, 2025
Skin, as the largest organ of the body, possesses various physiological functions including barrier, absorption, sensation, thermoregulation, metabolism, and immunity.
The Origin of Mesenchymal Stem Cells and Their Role in Skin Injury Repair Xiaonisha
August 21, 2025
Among the traditional treatment methods for skin wound repair, skin grafting, biological scaffolds, skin flap surgery, and laser therapy are the most common.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part Two) Xiaomichong
July 09, 2024
In recent years, with the deepening of research into the pathogenesis of myelodysplastic syndromes (MDS), many novel drugs have emerged.
Advances in Research on New Therapeutic Drugs for Myelodysplastic Syndromes (Part one) Xiaomichong
July 09, 2024
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic malignancies characterized by defective normal hematopoiesis leading to a reduction in blood cells, with a risk of transformation into acute myeloid leukemia.
From CDMO Pharmaceutical Crisaborole First Generic Drug, Look at the Domestic PDE-4 Inhibitor R&D Development Layout Xiaobin
May 06, 2024
The NMPA official website showed that Zhejiang CDMO Pharmaceutical had submitted an application for the marketing application of crisaborole ointment as a generic drug and it was accepted by the Center for Drug Evaluation.
Domestic New Drug R&D Strength is Gradually Ascending, and Overseas Product Authorization is in Full Swing WND/PharmaSources
December 14, 2023
On November 13th, LEGN.US reached an 1 billion US dollar cooperation agreement with Novartis Pharmaceuticals.